Abstract:The amyloid β-peptide (Aβ) of Alzheimer's disease (AD) is generated by proteolysis within the transmembrane domain (TMD) of a C-terminal fragment of the amyloid β protein-precursor (APP CTFβ) by the γ-secretase complex. This processing produces Aβ ranging from 38 to 49 residues in length. Evidence suggests that this spectrum of Aβ peptides is the result of successive γ-secretase cleavages, with endoproteolysis first occurring at the ε sites to generate Aβ48 or Aβ49, followed by C-terminal trimming mostly every three residues along two product lines to generate shorter, secreted forms of Aβ: the primary Aβ49-46-43-40 line and a minor Aβ48-45-42-38 line. The major secreted Aβ species are Aβ40 and Aβ42, and an increased proportion of the longer, aggregation-prone Aβ42 compared to Aβ40 is widely thought to be important in AD pathogenesis. We examined TMD substrate determinants of the specificity and efficiency of ε site endoproteolysis and carboxypeptidase trimming of CTFβ by γ-secretase. We determined that the C-terminal negative charge of the intermediate Aβ49 does not play a role in its trimming by γ-secretase. Peptidomimetic probes suggest that γ-secretase has S1', S2', and S3' pockets, through which trimming by tripeptides may be determined. However, deletion of residues around the ε sites demonstrates that a depth of three residues within the TMD is not a determinant of the location of endoproteolytic ε cleavage of CTFβ. We also show that instability of the CTFβ TMD helix near the ε site significantly increases endoproteolysis, and that helical instability near the carboxypeptidase cleavage sites facilitates C-terminal trimming by γ-secretase. In addition, we found that CTFβ dimers are not endoproteolyzed by γ-secretase. These results support a model in which initial interaction of the array of residues along the undimerized single helical TMD of substrates dictates the site of initial ε cleavage and that helix unwinding is essential for both endoproteolysis and carboxypeptidase trimming.

Molecular mechanism of substrate recognition and cleavage by human γ-secretase

Recognition of the Amyloid Precursor Protein by Human Gamma-Secretase

Transmembrane Substrate Determinants for Γ-Secretase Processing of APP CTFβ

An internal docking site stabilizes substrate binding to γ-secretase: Analysis by molecular dynamics simulations

Recognition of the amyloid precursor protein by human γ-secretase

Substrate-Enzyme Interactions in Intramembrane Proteolysis: Γ-Secretase As the Prototype.

Initial Substrate Binding of Γ-Secretase: the Role of Substrate Flexibility.

Three-dimensional structure of human γ-secretase

Substrate-Enzyme Interactions in Intramembrane Proteolysis: -Secretase as the Prototype

The Gamma-Secretase Complex: from Structure to Function

Γ-Secretase, Evidence for Multiple Proteolytic Activities and Influence of Membrane Positioning of Substrate on Generation of Amyloid Β Peptides of Varying Length

Longer Forms of Amyloid Β Protein: Implications for the Mechanism of Intramembrane Cleavage by Γ-Secretase

Substrate check of γ-secretase

Enzyme-substrate hybrid β-sheet controls geometry and water access to the γ-secretase active site

Cleavage of amyloid precursor protein by an archaeal presenilin homologue PSH

Macromolecular complex in recognition and proteolysis of amyloid precursor protein in Alzheimer's disease

Substrate check of gamma-secretase.

An atomic structure of human γ-secretase

γ-Secretase Studied by Atomistic Molecular Dynamics Simulations: Global Dynamics, Enzyme Activation, Water Distribution and Lipid Binding

Conformational Changes and Unfolding of β-Amyloid Substrates in the Active Site of γ-Secretase

P4‐687: SUBSTRATE BINDING INHIBITS Γ‐secretase CLEAVAGE OF AMYLOID PRECURSOR PROTEIN